Mathieu Boniol

Mathieu Boniol

Professor Boniol in his Lyon office
Mathieu in his Lyon office

Mathieu Boniol was born in Nimes, France, and graduated in Biomathematics and Public Health at the University Lyon 1, France and subsequently obtained a PhD in epidemiology from the Université de Bourgogne, Dijon.

His scientific activities mainly deal with etiologic research based on epidemiological methods and meta-analytic methods. In particular, he has been involved in many analyses of temporal trends and of geographical patterns for exposures and outcomes.

Particular areas of expertise are the analysis of cancer registry data on trends in incidence and mortality of diseases, the analysis of exposure distribution and their impact on disease burden, statistical methods in pharmaco-epidemiology, evaluation of cancer screening and the analysis of disease registry data (e.g. linkage between biobanks and medical records) for the evaluation of health programmes or of medical activities. Mathieu Boniol has also contributed to various international collaborative projects involving computation of attributable fraction and to various meta-analyses (melanoma risk, artificial light and skin cancer, vitamin D and cancer).

Between 2003 and 2009, he held the position of Senior Biostatistician at the International Agency for Research on Cancer in Lyon. He was the coordinator of the EU-funded project EUROSUN. He is a member of the International Task Force on Skin Cancer Screening and Prevention that evaluates the national skin cancer screening in Germany. From 2009 to 2015, he was a member of the board of directors of Euroskin (the European Society of Skin Cancer Prevention) and President of Euroskin between 2011 and 2013.

In 2013, he was appointed as Professor at Strathclyde University, Glasgow. Mathieu Boniol is Vice-President, Biostatistics at the International Prevention Research Institute, where he supervises a team of statisticians, data managers and other functions. He has published more than 150 scientific articles and has an h-index of 33 (as of January 2017).



Sorry, comments are closed for this post.


Founded in 2009 with the broad goal of contributing to the improvement of health in populations worldwide, the International Prevention Research Institute (iPRI) aims to increase prospects for prevention through training, education, prevention research and research into causes worldwide with a focus on low and lower-middle income countries.

iPRI strives to answer three critical questions:

  • Is it healthy?
  • Is it safe?
  • Is it beneficial?

Contact iPRI

An iPRI staff member will respond promptly.